Thank you to Marathon Pharmaceuticals for providing updated information about deflazacort access and regulatory status during a webinar this week. The webinar addressed Marathon’s Expanded Access Program for deflazacort and what a potential FDA approval of deflazacort would mean in terms of access to the drug in the U.S. The webinar has been archived. https://cc.readytalk.com/play?id=hl12zw. Please watch and share this valuable information with others in the community.
#Marathon #Deflazacort #CureDuchenne.